Accessibility Menu
 
ProMIS Neurosciences logo

ProMIS Neurosciences

(NASDAQ) PMN

Current Price$12.05
Market Cap$25.94M
Since IPO (2012)-98%
5 Year-95%
1 Year-16%
1 Month-34%

ProMIS Neurosciences Financials at a Glance

Market Cap

$25.94M

Revenue (TTM)

$0.00

Net Income (TTM)

$39.72M

EPS (TTM)

$-23.42

P/E Ratio

-0.51

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$12.05

Volume

17,235

Open

$12.92

Previous Close

$12.05

Daily Range

$11.90 - $13.40

52-Week Range

$6.27 - $39.75

PMN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProMIS Neurosciences

Industry

Biotechnology

Employees

11

CEO

Neil K. Warma, MBA

Headquarters

Toronto, ON M4S 3E2, CA

PMN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-522%

Return on Capital

3%

Return on Assets

-0%

Earnings Yield

-1.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.94M

Shares Outstanding

2.15M

Volume

17.23K

Short Interest

0.00%

Avg. Volume

178.73K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$40.17M

EBITDA

$40.17M

Operating Cash Flow

$28.12B

Capital Expenditure

$0.00

Free Cash Flow

$28.12B

Cash & ST Invst.

$6.15M

Total Debt

$0.00

ProMIS Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$25.94M

N/A

Market Cap/Employee

$3.71M

N/A

Employees

7

N/A

Net Income

$10.67M

-4381.0%

EBITDA

$11.12M

-4569.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$6.15M

-53.8%

Accounts Receivable

$50.11K

-35.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-0.43%

N/A

Return on Invested Capital

3.27%

N/A

Free Cash Flow

$9.05M

-9.9%

Operating Cash Flow

$9.05M

-9.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MPLTMapLight Therapeutics, Inc.
$27.02+2.70%
LPCNLipocine Inc.
$2.53+6.30%
OSRHOSR Holdings, Inc.
$0.52-3.21%
EDSAEdesa Biotech, Inc.
$5.22-11.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.35-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.54+0.07%
AALAmerican Airlines Group
$12.13+0.08%
SNAPSnap
$5.60+0.09%

Questions About PMN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.